Construction and validation of a personalized nomogram of ultrasound for pretreatment prediction of breast cancer patients sensitive to neoadjuvant chemotherapy

1. Siegel RL, , Miller KD, , Fuchs HE, , Statistics JAC. Cancer statistics. Ca: A Cancer Journal for Clinicians 2021; 71: 7–33.

2. Kim R, , Osaki A, , Toge T. Current and future roles of neoadjuvant chemotherapy in operable breast cancer. Clin Breast Cancer 2005; 6: 223–32. doi: https://doi.org/10.3816/CBC.2005.n.024

3. Ogston KN, , Miller ID, , Payne S, , Hutcheon AW, , Sarkar TK, , Smith I, , et al.. A new histological grading system to assess response of breast cancers to primary chemotherapy: prognostic significance and survival. Breast 2003; 12: 320–27. doi: https://doi.org/10.1016/s0960-9776(03)00106-1

4. Cortazar P, , Zhang L, , Untch M. Pathological complete response and long-term clinical benefit in breast cancer: the CT neobc pooled analysis. Lancet 2019; 393: 986.

5. Fujita T. Pathological complete response in breast cancer. Lancet 2015; 385: S0140-6736(15)60016-2. doi: https://doi.org/10.1016/S0140-6736(15)60016-2

6. Wang H, , Mao X. Evaluation of the efficacy of neoadjuvant chemotherapy for breast cancer. Drug Des Devel Ther 2020; 14: 2423–33. doi: https://doi.org/10.2147/DDDT.S253961

7. Braman NM, , Etesami M, , Prasanna P, , Dubchuk C, , Gilmore H, , Tiwari P, , et al.. Intratumoral and peritumoral radiomics for the pretreatment prediction of pathological complete response to neoadjuvant chemotherapy based on breast DCE-MRI. Breast Cancer Res 2017; 19: 57. doi: https://doi.org/10.1186/s13058-017-0846-1

8. Antunovic L, , De Sanctis R, , Cozzi L, , Kirienko M, , Sagona A, , Torrisi R, , et al.. Pet/Ct radiomics in breast cancer: promising tool for prediction of pathological response to neoadjuvant chemotherapy. Eur J Nucl Med Mol Imaging 2019; 46: 1468–77. doi: https://doi.org/10.1007/s00259-019-04313-8

9. Montemezzi S, , Benetti G, , Bisighin MV, , Camera L, , Zerbato C, , Caumo F, , et al.. 3T DCE-MRI radiomics improves predictive models of complete response to neoadjuvant chemotherapy in breast cancer. Front Oncol 2021; 11: 630780. doi: https://doi.org/10.3389/fonc.2021.630780

10. Rauch GM, , Adrada BE, , Kuerer HM, , van la Parra RFD, , Leung JWT, , Yang WT. Multimodality imaging for evaluating response to neoadjuvant chemotherapy in breast cancer. AJR Am J Roentgenol 2017; 208: 290–99. doi: https://doi.org/10.2214/AJR.16.17223

11. Hayashi M, , Yamamoto Y, , Iwase H. Clinical imaging for the prediction of neoadjuvant chemotherapy response in breast cancer. Chin Clin Oncol 2020; 9: 31. doi: https://doi.org/10.21037/cco-20-15

12. Yeh E, , Slanetz P, , Kopans DB, , Rafferty E, , Georgian-Smith D, , Moy L, , et al.. Prospective comparison of mammography, sonography, and MRI in patients undergoing neoadjuvant chemotherapy for palpable breast cancer. AJR Am J Roentgenol 2005; 184: 868–77. doi: https://doi.org/10.2214/ajr.184.3.01840868

13. Peintinger F, , Kuerer HM, , Anderson K, , Boughey JC, , Meric-Bernstam F, , Singletary SE, , et al.. Accuracy of the combination of mammography and sonography in predicting tumor response in breast cancer patients after neoadjuvant chemotherapy. Ann Surg Oncol 2006; 13: 1443–49. doi: https://doi.org/10.1245/s10434-006-9086-9

14. Hassani C, , Varghese BA, , Nieva J, , Duddalwar V. Radiomics in pulmonary lesion imaging. AJR Am J Roentgenol 2019; 212: 497–504. doi: https://doi.org/10.2214/AJR.18.20623

15. Yu Y, , He Z, , Ouyang J, , Tan Y, , Chen Y, , Gu Y, , et al.. Magnetic resonance imaging radiomics predicts preoperative axillary lymph node metastasis to support surgical decisions and is associated with tumor microenvironment in invasive breast cancer: a machine learning, multicenter study. EBioMedicine 2021; 69: 103460: S2352-3964(21)00253-X. doi: https://doi.org/10.1016/j.ebiom.2021.103460

16. Zheng X, , Yao Z, , Huang Y, , Yu Y, , Wang Y, , Liu Y, , et al.. Author correction: deep learning radiomics can predict axillary lymph node status in early-stage breast cancer. Nat Commun 2021; 12(1): 4370. doi: https://doi.org/10.1038/s41467-021-24605-8

17. Mao N, , Shi Y, , Lian C, , Wang Z, , Zhang K, , Xie H, , et al.. Intratumoral and peritumoral radiomics for preoperative prediction of neoadjuvant chemotherapy effect in breast cancer based on contrast-enhanced spectral mammography. Eur Radiol 2022; 32: 3207–19. doi: https://doi.org/10.1007/s00330-021-08414-7

18. Pesapane F, , Rotili A, , Botta F, , Raimondi S, , Bianchini L, , Corso F, , et al.. Radiomics of MRI for the prediction of the pathological response to neoadjuvant chemotherapy in breast cancer patients: a single referral centre analysis. Cancers (Basel) 2021; 13(17): 4271. doi: https://doi.org/10.3390/cancers13174271

19. Granzier RWY, , Ibrahim A, , Primakov SP, , Samiei S, , van Nijnatten TJA, , de Boer M, , et al.. Mri-Based radiomics analysis for the pretreatment prediction of pathologic complete tumor response to neoadjuvant systemic therapy in breast cancer patients: a multicenter study. Cancers (Basel) 2021; 13(10): 2447. doi: https://doi.org/10.3390/cancers13102447

20. Chen S, , Liu Y, , Ouyang Q-W, , Huang L, , Luo R-C, , Shao Z-M. Clinical and pathological response to neoadjuvant chemotherapy based on primary tumor reduction is correlated to survival in hormone receptor-positive but not hormone receptor-negative locally advanced breast cancer. Ann Surg Oncol 2015; 22: 32–39. doi: https://doi.org/10.1245/s10434-014-3894-0

21. Sataloff DM, , Mason BA, , Prestipino AJ, , Seinige UL, , Lieber CP, , Baloch Z. Pathologic response to induction chemotherapy in locally advanced carcinoma of the breast: a determinant of outcome. J Am Coll Surg 1995; 180: 297–306.

22. Dobruch-Sobczak K, , Piotrzkowska-Wróblewska H, , Klimonda Z, , Karwat P, , Roszkowska-Purska K, , Clauser P, , et al.. Multiparametric ultrasound examination for response assessment in breast cancer patients undergoing neoadjuvant therapy. Sci Rep 2021; 11(1): 2501. doi: https://doi.org/10.1038/s41598-021-82141-3

23. Kim R, , Chang JM, , Lee H-B, , Lee SH, , Kim S-Y, , Kim ES, , et al.. Predicting axillary response to neoadjuvant chemotherapy: breast MRI and US in patients with node-positive breast cancer. Radiology 2019; 293: 49–57. doi: https://doi.org/10.1148/radiol.2019190014

24. Makanjuola DI, , Alkushi A, , Al Anazi K. Defining radiologic complete response using a correlation of presurgical ultrasound and mammographic localization findings with pathological complete response following neoadjuvant chemotherapy in breast cancer. Eur J Radiol 2020; 130: 109146: S0720-048X(20)30335-1. doi: https://doi.org/10.1016/j.ejrad.2020.109146

25. Ye P, , Duan H, , Zhao Z, , Fang S. A practical predictive model based on ultrasound imaging and clinical indices for estimation of response to neoadjuvant chemotherapy in patients with breast cancer. Cancer Manag Res 2021; 13: 7783–93. doi: https://doi.org/10.2147/CMAR.S331384

26. Lamb PM, , Perry NM, , Vinnicombe SJ, , Wells CA. Correlation between ultrasound characteristics, mammographic findings and histological grade in patients with invasive ductal carcinoma of the breast. Clin Radiol 2000; 55: 40–44. doi: https://doi.org/10.1053/crad.1999.0333

27. Savaridas SL, , Sim YT, , Vinnicombe SJ, , Purdie CA, , Thompson AM, , Evans A. Are baseline ultrasound and mammographic features associated with rates of pathological completes response in patients receiving neoadjuvant chemotherapy for breast cancer? Cancer Imaging 2019; 19: 67. doi: https://doi.org/10.1186/s40644-019-0251-3

28. Court L, , Faye X, , Zhou S. Introduction to radiomics. Med Phys Mex Symp Med Phys 2018; 45: e586.

29. Yip SSF, , Aerts HJWL. Applications and limitations of radiomics. Phys Med Biol 2016; 61: R150–66. doi: https://doi.org/10.1088/0031-9155/61/13/R150

30. Yang M, , Liu H, , Dai Q, , Yao L, , Zhang S, , Wang Z, , et al.. Treatment response prediction using ultrasound-based pre-, post-early, and delta radiomics in neoadjuvant chemotherapy in breast cancer. Front Oncol 2022; 12: 748008. doi: https://doi.org/10.3389/fonc.2022.748008

31. Bian T, , Wu Z, , Lin Q, , Wang H, , Ge Y, , Duan S, , et al.. Radiomic signatures derived from multiparametric MRI for the pretreatment prediction of response to neoadjuvant chemotherapy in breast cancer. Br J Radiol 2020; 93: 1115: 20200287. doi: https://doi.org/10.1259/bjr.20200287

32. Huang X, , Mai J, , Huang Y, , He L, , Chen X, , Wu X, , et al.. Radiomic nomogram for pretreatment prediction of pathologic complete response to neoadjuvant therapy in breast cancer: predictive value of staging contrast-enhanced CT. Clin Breast Cancer 2021; 21: e388–401: S1526-8209(20)30332-3. doi: https://doi.org/10.1016/j.clbc.2020.12.004

33. Fan M, , Wu G, , Cheng H, , Zhang J, , Shao G, , Li L. Radiomic analysis of DCE-MRI for prediction of response to neoadjuvant chemotherapy in breast cancer patients. Eur J Radiol 2017; 94: 140–47: S0720-048X(17)30274-7. doi: https://doi.org/10.1016/j.ejrad.2017.06.019

34. Liu Z, , Li Z, , Qu J, , Zhang R, , Zhou X, , Li L, , et al.. Radiomics of multiparametric MRI for pretreatment prediction of pathologic complete response to neoadjuvant chemotherapy in breast cancer: a multicenter study. Clin Cancer Res 2019; 25: 3538–47. doi: https://doi.org/10.1158/1078-0432.CCR-18-3190

35. Granzier RWY, , Ibrahim A, , Primakov SP, , Samiei S, , van Nijnatten TJA, , de Boer M, , et al.. Mri-Based radiomics analysis for the pretreatment prediction of pathologic complete tumor response to neoadjuvant systemic therapy in breast cancer patients: a multicenter study. Cancers (Basel) 2021; 13(10): 2447. doi: https://doi.org/10.3390/cancers13102447

36. Jiang M, , Li C-L, , Luo X-M, , Chuan Z-R, , Lv W-Z, , Li X, , et al.. Ultrasound-based deep learning radiomics in the assessment of pathological complete response to neoadjuvant chemotherapy in locally advanced breast cancer. Eur J Cancer 2021; 147: 95–105: S0959-8049(21)00048-4. doi: https://doi.org/10.1016/j.ejca.2021.01.028

留言 (0)

沒有登入
gif